secwatch.observer — SEC 8-K summary
======================================

Issuer:     ADIAL PHARMACEUTICALS, INC. (ADIL)
CIK:        0001513525
Form:       8-K
Filed at:   2026-08-25T20:33:05+00:00
Accession:  0001213900-26-093544
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 3.02
LLM model:  deepseek-v4-flash:cloud@v2

Adial grants 307,814-share option at $5.76 to new employee
----------------------------------------------------------

- On Aug 19, 2026, Adial granted an option for 307,814 shares at $5.76 exercise price to a new hire.
- Option has 10-year term; vests 25% after first anniversary, then monthly installments over 4 years.
- Grant approved by Compensation Committee under Nasdaq inducement exception Rule 5635(c)(4).
- Option issued outside equity incentive plans and relies on Section 4(a)(2) exemption.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1513525/000121390026093544/0001213900-26-093544-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1513525/000121390026093544/ea0303369-8k_adial.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-093544

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer